The results indicated that Met at 10 μM, a physiologically relevant concentration, could enhance the IFNγ production by CD8+ T cells upon TCR stimulation and that Met at concentrations high enough to downregulate OCR of tumor cells, hampered the IFNγ production of CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.